Literature DB >> 29348305

The evolving clinical, genetic and therapeutic landscape of multiple endocrine neoplasia type 2.

Serisha Moodley1, Frank Weber2, Lois M Mulligan3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29348305     DOI： 10.1530/ERC-17-0488

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN： 1351-0088            Impact factor:   5.678


× No keyword cloud information.
  5 in total

1.  The RET C611Y mutation causes MEN 2A and associated cutaneous lichen amyloidosis.

Authors:  Xiao-Ping Qi; Jian-Zhong Peng; Xiao-Wei Yang; Zhi-Lie Cao; Xiu-Hua Yu; Xu-Dong Fang; Da-Hong Zhang; Jian-Qiang Zhao
Journal:  Endocr Connect       Date:  2018-07-26       Impact factor: 3.335

Review 2.  5P Strategies for Management of Multiple Endocrine Neoplasia Type 2: A Paradigm of Precision Medicine.

Authors:  Shu-Yuan Li; Yi-Qiang Ding; You-Liang Si; Mu-Jin Ye; Chen-Ming Xu; Xiao-Ping Qi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-18       Impact factor: 5.555

3.  Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in China.

Authors:  Xiao-Ping Qi; Jian-Qiang Zhao; Xu-Dong Fang; Bi-Jun Lian; Feng Li; Hui-Hong Wang; Zhi-Lie Cao; Wei-Hui Zheng; Juan Cao; Yu Chen
Journal:  BMC Cancer       Date:  2021-04-07       Impact factor: 4.430

4.  Tumor characteristics and surgical outcome in incidentally discovered pheochromocytomas and paragangliomas.

Authors:  Xinlei Chen; Liru Hu; Caojie Liu; Guangcheng Ni; Yuwei Zhang
Journal:  Endocr Connect       Date:  2018-09-01       Impact factor: 3.335

5.  The RET C611Y mutation causes MEN 2A and associated cutaneous

Authors:  Xiao-Ping Qi; Jian-Zhong Peng; Xiao-Wei Yang; Zhi-Li Zao; Xiu-Hua Yu; Xu-Dong Fang; Da-Hong Zhang; Jian-Qiang Zhao
Journal:  Endocr Connect       Date:  2018-09-01       Impact factor: 3.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.